Thursday, August 11th, 2022 12:13:21

WHO to resume hydroxychloroquine coronavirus trials

Updated: June 4, 2020 12:35 pm

World Health Organization Director-general, Tedros Adhanom Ghebreyesus said that WHO will resume its trial of hydroxychloroquine for potential use against the coronavirus,  after those running the study briefly stopped giving it to new patients over health concerns. Speaking at an online media briefing he said that WHO experts had advised the continuation of all trials including hydroxychloroquine.

The U.N. agency last month paused its large study of HCQ treatments against COVID-19 in which newly enrolled patients were getting the anti-malarial drug due to fears of increased death rates and irregular heartbeats.

Comments are closed here.